GL1X · GenesisL1 explorer

MolNFT v1 · #112851 · protein

Crystal structure of SGCC5 protein from streptomyces globisporus (complex with (R)-(-)-1-(2-naphthyl)-1,2-ethanediol and sucrose)

4ZXW · C-domain type II peptide synthetase: “Crystal structure of SGCC5 protein from streptomyces globisporus (complex with…”. X-ray diffraction, 4 ligands (4T7, GLC, FRU), 12 pockets (best druggability 0.86). MolNFT v1 #112851 on…

PDB
4ZXW
Type
protein
Length
886 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
C-domain type II peptide synthetase
UniProt
Q8GMG2
Ligands
4T7, GLC, FRU, SO4
Pockets
12 · best druggability 0.86

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BC-domain type II peptide synthetaseprotein44340% helix, 23% strandQ8GMG2

Ligands and binding sites

  • 4T7 · (1R)-1-(naphthalen-2-yl)ethane-1,2-diol · ligand · 2 copies · chains A, B
  • GLC · alpha-D-glucopyranose · sugar · 2 copies · chains A, B
  • FRU · beta-D-fructofuranose · sugar · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 5 copies · chains A, B
  • CXS · 3-cyclohexyl-1-propylsulfonic acid · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14050.860.9452GLC, FRU, 4T7
24080.860.9453GLC, FRU, 4T7
36580.700.7867empty
41750.630.8429empty
51740.620.8427empty

Interfaces

1 interface between chains.

  • A–B · 668 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 4ZXW · Crystal structure of SgcC5 protein from Streptomyces globisporus (complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.